Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov​.

FOCUS: how Americans benefit from global health research

May / June 2017 | Volume 16, Issue 3

To protect the health and safety of Americans, Fogarty has for three decades managed grant programs that build scientific expertise in developing countries, ensuring there is local capacity to detect and address pandemics at their point of origin, contain outbreaks and minimize their impact. Fogarty also convenes the best scientific minds to address critical global health research problems such as pandemic response, antimicrobial resistance and strengthening research capacity in Africa.

Whether developing scientific expertise to help contain and manage diseases such as Ebola and Zika, or enabling unique research abroad to advance our understanding of Alzheimer’s disease, Fogarty programs are laying the foundation that makes research possible in many low- and middle-income countries.

Featured Articles

• Zika vaccine trial site in Peru led by Fogarty trainee
• Fogarty-supported Chagas, dengue researchers redirect efforts to tackle Zika virus
• HIV research by Fogarty trainees brings changes to US treatment protocols
• Fogarty trainees study Colombian family for clues to prevent Alzheimer's
• Fogarty protects US by strengthening pandemic response in West Africa

Related Resources

• Fact sheets detailing Fogarty's history, key accomplishments, economic impact and other information for downloading and easy printing.

To view Adobe PDF files, download current, free accessible plug-ins from Adobe's website.